Transcend Capital Advisors LLC Sells 1,484 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Transcend Capital Advisors LLC reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.9% in the 4th quarter, HoldingsChannel reports. The firm owned 49,350 shares of the exchange traded fund’s stock after selling 1,484 shares during the period. Transcend Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $4,444,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Golden State Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $29,000. Avior Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the last quarter. Tidemark LLC raised its holdings in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares during the period. Quintet Private Bank Europe S.A. acquired a new stake in SPDR S&P Biotech ETF during the third quarter worth approximately $40,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $43,000.

SPDR S&P Biotech ETF Trading Up 0.2 %

Shares of NYSEARCA XBI opened at $92.72 on Friday. The firm has a market cap of $7.07 billion, a P/E ratio of 11.47 and a beta of 1.11. The business’s 50 day moving average is $91.39 and its 200-day moving average is $95.98. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.